<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    CareDx, Inc.

    CareDx, Inc.

    CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics co...

    CareDx, Inc., headquartered in Brisbane, Califo...

    Filing Type:    PU
    Achieve Life Sciences, Inc.

    Achieve Life Sciences, Inc.

    Achieve is a specialty pharmaceutical company committed to advancing cytisinicline...

    Achieve is a specialty pharmaceutical company c...

    Filing Type:    PU
    MedAnswers

    MedAnswers

    With 40 million infertile people worldwide, MedAnswers connects patients with mult...

    With 40 million infertile people worldwide, Med...

    Amount Raised:    $145,702.50
    Fundraising Status:    EC
    Filing Type:    CF
    Robovet Corporation

    Robovet Corporation

    Robovet Corporation has developed a new MR imaging technology that can also help t...

    Robovet Corporation has developed a new MR imag...

    Amount Raised:    $136,889.00
    Fundraising Status:    EC
    Filing Type:    CF
    AtriCure, Inc.

    AtriCure, Inc.

    As a leading provider of innovative technologies for the treatment of Atrial Fibri...

    As a leading provider of innovative technologie...

    Filing Type:    PU
    Kazia Therapeutics Limited

    Kazia Therapeutics Limited

    Kazia Therapeutics is an oncology-focused biotechnology company, developing innova...

    Kazia Therapeutics is an oncology-focused biote...

    Filing Type:    PU
    Medpace Holdings, Inc.

    Medpace Holdings, Inc.

    Medpace is a scientifically-driven, global, full-service clinical contract researc...

    Medpace is a scientifically-driven, global, ful...

    Filing Type:    PU
    Twist Bioscience Corporation

    Twist Bioscience Corporation

    We are a leading, rapidly growing synthetic biology company that has developed a d...

    We are a leading, rapidly growing synthetic bio...

    Filing Type:    PU
    Goods Unite Us, Inc.

    Goods Unite Us, Inc.

    Our mission is to empower people to become political consumers so we can put an en...

    Our mission is to empower people to become poli...

    Fundraising Status:    SD
    Filing Type:    CF
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.